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Background: Prior studies of symptoms in heart failure (HF) were largely cross-sectional
and symptoms were measured using retrospective recall. Because negative emotions influ
ence information processing, retrospective symptom reports by patients with depressive
symptoms and anxiety may be biased. The purpose of this study was to determine whether
there are differences in patterns of symptom changes, measured prospectively, over 15 days
by levels of depressive symptoms and anxiety.
Methods: HF patients (N=52) rated daily symptom severity for shortness of breath
(SOB), fatigue, sleep disturbance, and edema over 15 days on a 10-point visual analogue
scale. Patients were grouped into higher vs lower levels of depressive symptoms and
anxiety, respectively, based on median scores of Brief Symptom Inventory subscales.
Latent growth curve modeling was used to examine whether patterns of symptom
changes over 15 days differed in higher vs lower levels of depressive symptom and
anxiety groups.
Results: Those in the higher depressive symptom group had lower levels of baseline
symptom severity in SOB (β: −1.46), fatigue (β: −1.71), sleep disturbance (β: −1.78), and
edema (β: −1.97) than those in the lower depressive symptom group. However, there were no
significant differences in rates of changes in the severity of any of the four symptoms
between groups. Anxiety was not associated with baseline severity of symptoms or rates
of changes in any of the four symptoms.
Conclusion: Depressive symptoms, but not anxiety, were associated with daily symptom
experience. HF patients with higher levels of depressive symptoms may perceive their
symptom severity differently than patients with lower levels of depressive symptoms.
Keywords: depressive symptoms, anxiety, heart failure, symptoms
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Heart failure (HF) is a serious health concern in the United States with high volume
and staggering Medicare program expenditure. In the United States, approximately
5.7 million adults have HF, and an additional 3 million will have HF by 2030.1 HF
is the most common reason for hospital admissions among Medicare beneficiaries,
with 40% and 65% of rehospitalization rates at 3 months and 1 year.2
Accurate symptom perception is essential for patients with HF to effectively
manage their HF, seek care in a timely manner, and prevent repeated hospitalizations.3
However, some patients wait up to 7 days or more before seeking medical help.4,5
About 40% of HF patients who had been diagnosed with HF for more than 2 months
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admitted that they were unable to recognize typical symp
toms of HF, such as dyspnea, fatigue and orthopnea, as
evidence of worsening HF.6
The Common-Sense Model of Illness Representations
describes how individuals respond to health threats by
forming
two
distinct
dimensions
of
illness
7
representations. Cognitive illness representations can be
shaped based on the information available to the indivi
duals (eg, previous experiences and knowledge).
Emotional illness representations capture feelings related
to illness. The model suggests that cognitive and emo
tional illness representations are interrelated and simulta
neously influence individuals’ responses to health threats.
Previous studies have showed that the two dimensions of
illness representations are associated with health-related
behaviors and outcomes in a variety of groups of patients
including patients with HF.8–10
Negative emotions, such as depression and anxiety, are
barriers to accurate symptom perception because negative
emotions affect cognitive processing, such as attention and
memory.11–13 Patients with higher levels of depressive
symptoms and lower levels of anxiety are more likely to
have longer delay time from the onset of worsening HF to
care-seeking.4,14 Depressive symptoms independently pre
dicted the number of physical symptoms that HF patients
experienced over 7 days after adjusting for clinical and
demographic factors (ie, N-terminal pro-brain natriuretic
peptide, age, and race).15 These findings suggest that
negative emotions influence symptom perception in the
HF population.
Howren and Suls found that depressive and anxious
moods have a differential effect on retrospective and con
current symptom reporting.12 In their study, depressed
mood was related to inflation of retrospective symptom
reporting, while anxious mood was related to the inflation
of concurrent symptom reporting.12 However, prior studies
of symptoms in HF in relation to depressive symptoms and
anxiety have been mostly cross-sectional and relied on
retrospective recall of symptoms (eg, symptom experi
ences during the past week).15,16 This limits our under
standing of how the day-to-day symptom experience in HF
patients is influenced by depressive symptoms and anxiety.
To address this gap in knowledge, it is important to
prospectively investigate the association between HF
symptom assessment and depressive symptoms and anxi
ety. The purpose of this study was to determine whether
there are differences in patterns of symptom severity in
four major HF symptoms (ie, shortness of breath [SOB],
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fatigue, sleep disturbances, and edema) over 15 days
between patients with higher and lower levels of depres
sive symptoms and anxiety, respectively.

Methods
This study was a prospective, longitudinal study in which we
compared patients’ symptom ratings for 15 consecutive days
by levels of depressive symptoms and anxiety. Patients were
recruited from cardiology clinics affiliated with three aca
demic institutions in the United States and Australia. The
Institutional Review Boards of all participating institutions
(University of Kentucky and Australian Catholic University)
approved this study. This study conforms to the principles of
the Declaration of Helsinki. Written, signed informed con
sent was sought and obtained from all participants.

Participants
Patients ≥ 21 years of age with a physician-confirmed diag
nosis of HF were eligible for this study. Patients were
excluded for an acute myocardial infarction in the 3 months
prior to the study enrollment, changes in medication regimens
in the 3 months prior to the study, a stroke with neurological
impairment, life-threatening comorbidities (eg, cancer with
active treatment and end-stage renal disease), obvious cogni
tive impairments, or inability to read or understand English.

Procedures
Cardiologists and nurses in the clinics consecutively referred
patients who met the inclusion/exclusion criteria. Patients
were invited to participate in the study and gave signed,
written informed consent. After obtaining informed consent,
baseline appointments were scheduled. At baseline, patients
were asked to complete questionnaires to assess socio-demo
graphic and clinical factors, depressive symptoms, and anxi
ety. Medical records were reviewed to obtain clinical
characteristics, such as left ventricular ejection fraction
(LVEF). After patients completed the questionnaires, trained
research nurses provided patients with a symptom diary to rate
their symptoms for 15 days after returning to home and taught
them in detail how to complete the diary (eg, rate symptoms at
the same time every day). When patients returned their com
pleted symptom diaries, research nurses reviewed the diary
with patients to resolve ambiguities in ratings.

Measures
Symptom Diary
Daily symptoms were assessed with the Daily Symptom
Scale,17 which is a self-report, paper-pencil type of the
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symptom diary. Patients are asked to rate the severity of
four symptoms (ie, SOB, fatigue, sleep disturbance, and
edema) daily for 15 days. Symptom severity was rated
using a 10-point visual analog scale with 0 indicating the
absence of symptom and 10 indicating the worst the
symptom could be.

Depressive Symptoms and Anxiety
Depressive symptoms and anxiety were measured using
the Brief Symptom Inventory (BSI) subscales for depres
sive symptoms and anxiety, respectively.18 The advantage
of using the BSI over other measures (eg, Beck Depression
Inventory) is that there are no somatic symptom items,
such as sleep disturbances, which may be confounded with
HF symptoms and the instrument is short and easy to
understand.
There are six items per each subscale of BSI.
Patients are asked to rate how much they have been
bothered by symptoms of depression or anxiety in the
past 7 days on a 5-point scale (0= “not at all” to
4=“extremely”). Total scores are obtained by averaging
item scores and can range from 0 to 4, with higher
scores indicating higher levels of depressive symptoms
and anxiety. The validity and reliability of the BSI have
been demonstrated.18

Sociodemographic and Clinical Data
Data on following variables were collected via patient
interview and medical records review: age, gender, ethni
city, living arrangement, LVEF, New York Heart
Association (NYHA) functional classification, comorbid
ities, and medication regimens. Patients were categorized
as having either non-preserved systolic function (LVEF ≤
40%) or preserved systolic function (LVEF > 40%).
Trained research nurse carefully conducted in-depth struc
tured patient interviews to determine NYHA classification.

Statistical Analyses
Medians of baseline scores of the BSI subscale of depres
sive symptoms (median score= 0.5) and anxiety (median
score =0.5) were used to define higher vs lower levels of
depressive symptoms and anxiety because there are only
established cut-points for healthy adults. Independent ttests, Mann–Whitney test, chi-square tests, or Fisher’s
exact tests were used as appropriate to compare character
istics of patients between lower and higher levels of
depressive symptoms and anxiety.
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Latent growth curve modeling was done with Mplus
7.1. We built separate latent growth curve models by
median scores of depressive symptoms (ie, lower vs higher
levels of depressive symptoms groups) and anxiety (ie,
lower vs higher levels of anxiety groups).
We first built simple latent growth curves for four
symptoms (ie, SOB, fatigue, sleep disturbances, and
edema) for each depressive symptom groups (ie, higher
vs lower), to compare the average trajectory of symptom
severity for 15 consecutive days by levels of depressive
symptoms. We then incorporated covariates (ie, age, gen
der, and NYHA class) in the model to determine whether
depressive symptom groups are associated with the initial
level (ie, intercept) and rate of change (ie, slope) in symp
tom severity after adjusting for covariates. We followed
the same steps described above (latent growth curves
modeling without and with covariates) to compare the
average trajectory of symptom severity between patients
with higher and lower levels of anxiety.
The trajectory of symptom severity is characterized by
latent growth factors: an intercept (ie, estimate of baseline
level) and linear slope (ie, rate of change over time).
Model fit was examined with a standardized root-meansquare residual (SRMR<0.10), a root-mean-square error of
approximation (RMSEA <0.08), a comparative fit index
(CFI>0.90), and Tucker–Lewis Index (TLI >0.90).
Of 3120 symptom diary entries for 52 patients, 23
missing entries were found. Of 23 missing entries, there
were no missing entries for two or more consecutive days.
We imputed the missing values by averaging before and
after the missing values to yield a more complete data set
without a loss of power.

Results
Sample Characteristics
As shown in Table 1, the mean age of the patients (n=52)
was 61 years with a range of 23–87 years. The sample was
predominantly Caucasian, male, currently living with
someone, and overweight or obese. The majority of the
patients had non-preserved systolic function (LVEF ≤
40%). All patients were symptomatic (NYHA class II–
IV) and more than half of the patients were classified in
NYHA III/IV. The most common comorbid conditions
were hypertension followed by diabetes.
When comparing sample characteristics between patients
with lower and higher levels of depressive symptoms (Table
1), there were no significant differences except for gender
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Table 1 Sample Characteristics (N=52)
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Total

Lower Levels of

Higher Levels of

Lower Levels of

Higher Levels of

Depressive Symptoms

Depressive Symptoms

Anxiety (n=27)

Anxiety (n=25)

(n=26)

(n=26)

61 ± 14

63 ± 15

60 ± 13

65 ± 15

57 ± 11

Male

30 (57.7)

19 (73.1)

11 (42.3)

18 (66.7)

12 (48.0)

Female

22 (42.3)

7 (26.9)

15 (57.7)

9 (33.3)

13 (52.0)

45 (86.5)

23 (88.5)

22 (84.6)

24 (88.9)

21 (84.0)

34 (65.4)
18 (34.6)

17 (65.4)
9 (34.6)

17 (65.4)
9 (34.6)

17 (63.0)
10 (37.0)

17 (68.0)
8 (32.0)

11 ± 3

11 ± 3

12 ± 3

11 ± 3

12 ± 3

(n=49)
<25.0 (normal weight)

14 (28.6)

7 (28.0)

7 (29.2)

6 (24.0)

8 (33.3)

25.0–29.9 (overweight)

15 (30.6)

8 (32.0)

7 (29.2)

10 (40.0)

5 (20.8)

>30.0 (obese)

20 (40.8)

10 (40.0)

10 (41.7)

9 (36.0)

11 (45.8)

24 (46.2)
28 (53.8)

15 (57.7)
11 (42.3)

9 (34.6)
17 (65.4)

16 (59.3)
11 (40.7)

8 (32.0)
17 (68.0)

40 (81.6)

21 (91.3)

19 (73.1)

23 (95.8)

17 (68.0)

Age, yearsb
a

Gender

Living with someone
Ethnicity
Caucasian
Others
Education (n=51)
Body mass index (kg/m2)

NYHA Class

b

II
III/IV
Left ventricular ejection
fraction ≤ 40%b (n=49)
Comorbidities
Hypertension

38 (73.1)

16 (64.0)

22 (84.6)

19 (73.1)

19 (76.0)

CVA or stroke

7 (13.5)

2 (7.7)

5 (19.2)

3 (11.1)

4 (16.0)

Diabetes

19 (36.5)

11 (42.3)

8 (30.8)

9 (33.3)

10 (40.0)

ACE I or ARB (n=51)
Beta blockers

40 (76.9)
40 (76.9)

20 (76.9)
20 (76.9)

20 (80.0)
20 (76.9)

21 (77.8)
20 (74.1)

19 (79.2)
20 (80.0)

Diuretics

43 (82.7)

21 (80.8)

22 (84.6)

22 (81.5)

21 (84.0)

Digoxin
Antidepressant

21 (40.4)
8 (15.4%)

12 (46.2)
2 (7.7%)

9 (34.6)
6 (23.1%)

11 (40.7)
3 (11.1%)

10 (40.0)
5 (20.0%)

0.96 ± 0.95
0.73± 0.80

0.19 ± 0.22
0.24 ± 0.32

1.74 ± 0.73
1.22± 0.84

0.41± 0.64
0.17 ± 0.19

1.56± 0.87
1.33 ± 0.77

Medications

Depressive Symptomsa,b
Anxietya,b

Notes: Value=mean ± SD or N (%); Percentages may not sum to 100% due to rounding or missing values. aIndicates that group differences between higher and lower levels
of depressive symptoms; bIndicates that group differences between higher and lower levels of anxiety.
Abbreviations: NYHA, New York Heart Association; HF, heart failure; CVA, cerebrovascular accident; ACE I, angiotensin converting enzyme inhibitors; ARB, angiotensin II
receptor blockers.

and anxiety. Patients with higher levels of depressive symp
toms were more likely to be women and have higher levels of
anxiety than patients with lower levels of depressive symp
toms. Compared with patients with lower levels of anxiety,
patients with higher levels of anxiety were more likely to be
younger, have preserved systolic function (LVEF>40%), and
higher levels of depressive symptoms (Table 1).

1302

Powered by TCPDF (www.tcpdf.org)

submit your manuscript | www.dovepress.com

DovePress

Latent Growth Curve Modeling
Depressive Symptom Groups
Simple Latent Growth Curve Models
Overall, patients experienced no meaningful rates of changes
in SOB, fatigue, sleep disturbance, and edema over 15 days
(slopes for the four symptoms p-values > 0.05) between
patients with lower and higher levels of depressive

Psychology Research and Behavior Management 2020:13
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0.07

0.88/0.89

CFI/TLI

0.0001 (−0.002, 0.002)
0.06* (0.001, 0.12)
0.003 (−0.05, 0.06)

−0.02 (−0.06, 0.02)

0.40 (−0.75, 1.55)

−1.53* (−2.63, −0.42)

Age

Female (vs male)

NYHA class III/IV (vs II)

0.07

0.87/0.87

SRMR

CFI/TLI

0.83/0.83

0.12

0.14

0.002 (−0.11, 0.11)

0.06 (−0.06, 0.17)

−0.18 (−1.54, 1.19)
−0.06 (−1.38, 1.26)

−0.003 (−0.01, 0.001)

0.02 (−0.10, 0.13)

−0.24 (−0.06, 0.16)

0.01 (−0.04, 0.06)

−1.71* (−3.08, −0.34)

0.83/0.85

0.14

0.15

−1.87* (−3.13, −0.61)

Slope (95% CI)

0.82/0.82

0.06

0.16

−0.76 (−2.28, 0.76)

−0.51 (−2.08, 1.06)

0.03 (−0.03, 0.08)

−1.78* (−3.35, −0.20)

0.84/0.85

0.06

0.17

−2.18* (−3.66, −0.70)

Intercept (95% CI)

Sleep Disturbance

0.023 (−0.06, 0.11)

0.02 (−0.07, 0.11)

−0.004* (−0.01, −0.001)

−0.002 (−0.09, −0.09)

0.02 (−0.07, −0.10)

Slope (95% CI)

0.89/0.89

0.03

0.15

0.13 (−1.64, 1.89)

0.44 (−1.38, 2.26)

0.02 (−0.04, 0.08)

−1.97* (−3.79, −0.14)

0.89/0.90

0.03

0.17

−1.91* (−3.59, −0.23)

Intercept (95% CI)

Edema

0.03 (−0.04, 0.10)

−0.04 (−0.11, 0.04)

0.0001 (−0.003, 0.002)

0.01 (−0.06, 0.09)

0.01 (−0.06, 0.08)

Slope (95% CI)

Note: *= p-value < 0.05.
Abbreviations: CI, confidence interval; RMSEA, root mean square error of approximation; SRMR, standardized root mean square residual; CFI, comparative fit index; TLI, Tucker–Lewis Index; NYHA, New York Heart Association.

0.14

RMSEA

Fit index

−0.04 (−0.10, 0.02)

−1.46* (−2.60, −0.32)

−0.12 (−0.08, 0.03)

Depressive symptom
groups

Adjusted Latent Growth Curve Models

0.15

SRMR

−1.17* (−2.84,−0.75)

RMSEA

Fit index

Depressive symptom
groups

Simple Latent Growth Curve Models

Intercept (95% CI)

Intercept (95% CI)

Slope (95% CI)

Fatigue

Shortness of Breath

Table 2 Latent Growth Curve Models for Depressive Symptoms (n=52)
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symptoms (Table 2). However, patients with higher levels of
depressive symptoms had lower scores of baseline symptom
severity (intercept) by 1.17 (95% confidence interval [CI] =
−2.84, −0.75), 1.87 (95% CI=−3.13, −0.61), 2.18 (95% CI=
−3.66, −0.70), and 1.91 points (95% CI=−3.59, −0.23) for
SOB, fatigue, sleep disturbance, and edema, respectively,
than patients with lower levels of depressive symptoms.
Adjusted Latent Growth Curve Models
There were no significant differences in rates of changes
(slopes) in the severity of any of the four symptoms between
the two groups after controlling for age, gender, and NYHA
class (Figure 1). However, patients with higher levels of
depressive symptoms had lower levels of baseline symptom

severity (intercepts) over 15 days in SOB (β: −1.46, 95% CI=
−2.60, −0.32), fatigue (β: −1.71, 95% CI=−3.08, −0.34), sleep
disturbance (β: −1.78, 95% CI=−3.35, −0.20), and edema (β:
−1.97, 95% CI=−3.79, −0.14) compared to patients with
lower levels of depressive symptoms after adjusting for age,
gender and NYHA class (Table 2). This indicates that HF
patients with higher levels of depressive symptoms experi
enced consistently lower symptom severity over 15 days than
patients with lower levels of depressive symptoms.
Examining the covariates, women experienced a posi
tive rate of changes in SOB severity (β: 0.06, 95%
CI=0.001, 0.12), indicating a small increase in severity
of SOB over 15 days compared to men. Patients in
NYHA II reported higher scores of SOB severity at

Figure 1 Trajectory of symptom severity by depressive symptoms (n=52).
Notes: ■ = Lower levels of depressive symptoms (raw). ● = Lower levels of depressive symptoms (projected). ◆ = Higher levels of depressive symptoms (raw). ▲ =
Higher levels of depressive symptoms (projected). The panels (A–D) = shortness of breath, fatigue, sleep disturbance, and edema, respectively. X-axis indicates number of
days and y-axis indicates levels of symptoms. The baseline symptom severity in all four symptoms (shortness of breath, fatigue, sleep disturbance, and edema) was
significantly different between patients with higher and lower levels of depressive symptoms. However, there were no significant differences in the rates of changes in any of
the four symptoms between the two groups.
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0.07

0.88/0.89

CFI/TLI

0.0001 (−0.002, 0.002)
0.05 (−0.01, 0.11)
−0.003 (−0.06, 0.06)

−0.03 (−0.07, 0.02)

0.11 (−1.05, 1.26)

−1.61* (−2.77, −0.44)

Age

Female (vs male)

NYHA class III/IV (vs II)

0.07

0.87/0.87

SRMR

CFI/TLI

0.83/0.83

0.12

0.13

0.02 (−0.10, 0.13)

0.07 (−0.04, 0.18)

−0.52 (−1.89, 0.847)
−0.12 (−1.51, 1.26)

−0.004 (−0.01, 0.0001)

−0.06 (−0.17, 0.06)

−0.01 (−0.12, 0.10)

0.005 (−0.05, 0.05)

−1.04 (−2.47, 0.40)

0.84/0.85

0.13

0.15

−1.21 (−2.53, 0.12)

Slope (95% CI)

0.82/0.82

0.06

0.16

−0.76 (−2.33, 0.81)

−0.82 (−2.36, 0.73)

0.02 (−0.04, 0.08)

−1.44 (−3.06, 0.19)

0.84/0.85

0.06

0.17

−1.94* (−3.48,
−0.41)

Intercept (95% CI)

Sleep Disturbance

0.02 (−0.07, 0.11)

0.02 (−0.07, 0.11)

−0.004* (−0.007, 0.0001)

0.001 (−0.09, 0.09)

0.04 (−0.05, 0.13)

Slope (95% CI)

0.89/0.89

0.03

0.15

−0.13 (−1.98, 1.73)

−0.05 (−1.88, 1.79)

0.02 (−0.05, 0.09)

−0.43 (−2.35, 1.49)

0.89/0.90

0.03

0.17

−0.64 (−2.42, 1.13)

Intercept (95%
CI)

Edema

0.03 (−0.04, 0.11)

−0.03 (−0.10, 0.04)

−0.001 (−0.003, 0.002)

−0.004 (−0.08, 0.07)

0.004 (−0.07, 0.07)

Slope (95% CI)

Note: *= p-value < 0.05.
Abbreviations: CI, confidence interval; RMSEA, root mean square error of approximation; SRMR, standardized root-mean-square residual; CFI, comparative fit index; TLI, Tucker–Lewis Index; NYHA, New York Heart Association.

0.14

RMSEA

Fit index

−0.002 (−0.06, 0.06)

−0.83 (−2.03, 0.38)

0.003 (−0.05, 0.06)

Anxiety groups

Adjusted Latent Growth Curve Models

0.15

SRMR

−1.04 (−2.24, 0.158)

RMSEA

Fit index

Anxiety groups

Simple Latent Growth Curve Models

Intercept (95%
CI)

Intercept (95% CI)

Slope (95% CI)

Fatigue

Shortness of Breath

Table 3 Latent Growth Curve Models for Anxiety (n=52)
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Figure 2 Trajectory of symptom severity by anxiety (n=52).
Notes: ■ = Lower levels of anxiety (raw). ● = Lower levels of anxiety (projected). ◆ = Higher levels of anxiety (raw). ▲ = Higher levels of anxiety (projected). The panels
(A–D) = shortness of breath, fatigue, sleep disturbance, and edema, respectively. X-axis indicates number of days and y-axis indicates levels of symptoms. The baseline
symptom severity in any of the four symptoms (shortness of breath, fatigue, sleep disturbance, and edema) was not significantly different between patients with higher and
lower levels of anxiety. There were no significant differences in rates of changes in any of the four symptoms between the two groups.

baseline (intercept) by 1.53 points than patients in NYHA
III/IV (95% CI=−2.63, −0.42). Age was associated with a
negative rate of changes in sleep disturbance (β: −0.004,
95% CI=−0.01, −0.001), indicating a very small reduction
in severity of sleep disturbance over 15 days with age.

Anxiety Groups
Simple Latent Growth Curve Models
There were no significant rates of changes in SOB, fatigue,
sleep disturbance, and edema over 15 days (slopes for the
four symptoms p-values > 0.05) between patients with lower
and higher levels of anxiety (Table 3). There were no sig
nificant differences in baseline symptom severity (intercept)
between lower and higher levels of anxiety except for sleep
disturbance. Patients with higher levels of anxiety had lower
scores of baseline symptom severity (intercept) by 1.94
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points (95% confidence interval [CI] =−3.48, −0.41), for
sleep disturbance than patients with lower levels of anxiety.
Adjusted Latent Growth Curve Models
There were no significant differences in rates of changes
(slopes) and baseline symptom severity (intercepts) in any
of the four symptoms between patients with lower and
higher levels of anxiety symptoms, after controlling for
age, gender, and NYHA class (Figure 2).
Among covariates, age was associated with a negative
rate of changes in sleep disturbance severity (β: −0.004,
95% CI=−0.007, 0.0001), indicating a small decrease in
severity of sleep disturbance over 15 days as age increases.
Patients in NYHA II had higher scores of SOB severity at
baseline (intercept) by 1.61 points than patients in NYHA
III/IV (95% CI=−2.77, −0.44).
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Discussion
This is the first study on the relationship between negative
emotions (ie, depressive symptoms and anxiety) and dayto-day HF symptom experiences in patients with HF to be
conducted in a prospective manner. In this study, higher
levels of depressive symptoms were associated with lower
levels of symptom severity, a phenomenon that was stable
over time. However, anxiety was not associated with either
levels of or changes in symptom severity over time. These
results suggest that depressive symptoms and anxiety dif
ferentially influence patients’ daily symptom experiences.
HF patients with higher levels of depressive symptoms
appear to perceive their symptom severity differently
than patients with lower levels of depressive symptoms.
However, anxiety was not associated with symptom
experience over 15 days.
Symptoms are subjective sensations indicating a
departure from normal function. Symptoms are not
merely reflecting functional or structural abnormalities
in body systems, but rather the integrated experiences of
people in the context of their life situations.19,20 Thus,
symptoms are experienced in a unique way even among
people with the same symptoms and these experiences
are influenced by a variety of factors, such as age and
emotions.3,21,22
Negative emotions, such as depressive symptoms and
anxiety, influence information processing processes.11–13
Depressed people tend to deeply focus on self, engage
less in external environments, be ruminative to stimuli,
and recall negative experiences more strongly.22–24 These
characteristics of depressed people may contribute to an
inaccurate symptom perception, particularly symptom
reporting from retrospective recalls.
Howren and Suls12 conducted an experimental study in
which participants were asked two following questions
after mood induction: how many physical symptoms
were currently experienced and how many physical symp
toms had been experienced over 21 days. In their study,
participants in a depressed mood induction arm reported a
similar number of symptoms compared to those in a neu
tral mood induction arm. However, participants in a
depressed mood induction arm reported a significantly
larger number of physical symptoms when they were
asked to recall physical symptoms experienced over 21
days.12 Similarly, the more depressed patients suffering
from low back pain are, the greater inaccuracy in the recall
of pain compared to the actual daily diary pain were
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observed.25 These results indicate that depressive symp
toms may affect a recall of symptom experiences.
Bekelman and colleagues15 demonstrated the positive
relationship between depressive symptoms scores and the
number of physical symptoms experienced over the past
week in patients with HF. This finding reflects the general
notion that depressive symptoms may amplify physical
symptom complaints in HF. However, in our study HF
patients with higher levels of depressive symptoms con
sistently experienced lower levels of severity of physical
symptoms over 15 days. This conflicting finding in our
study may be related to the fact that we used a symptom
diary to prospectively assess symptoms instead of asses
sing symptom experiences by relying on recollection over
days or weeks. The memory bias in depressive symptoms
is consistently found in patients with HF in the present
study.
Unlike depression, in which recall bias is a unique
characteristic, hypervigilance for threatening information
is a distinctive feature of anxiety.24 Anxious people have a
disproportionate tendency to quickly recognize threatening
stimuli compared to neutral stimuli.24,26 People in a group
where an anxious mood was induced reported a larger
number of physical symptoms than people in groups
where depressed or neutral moods were induced.12
However, in our study anxiety was not related to daily
symptom experience. This might be related to the fact that
attention bias varies depending on levels of anxiety and
degree of intensity of threats.24,27 Regarding moderately
threatening cues, highly anxious people showed attentional
vigilance, while low anxious people showed attentional
avoidance.27 However, both highly and low anxious peo
ple exhibited attentional vigilance to highly threatening
cues.27 In our study, symptom severities for four physical
symptoms ranged from an average of 6–7 out of 10 points,
which might not be perceived as highly threatening levels
of symptoms by patients. Given that levels of symptom
severity in our sample were stable over 15 days, daily
similar levels of symptom severity might not be consid
ered as significant cues to patients’ HF condition, which
contributes to a lack of attention bias on daily symptom
experience in our study.
Overall, there were neither positive nor negative rates
of changes in symptom severity among HF patients
regardless of levels of depressive symptoms and anxiety
in our study. This may be related to the fact that we
recruited patients from out-patient settings who were rela
tively stable. As significant changes in weights exhibited

submit your manuscript | www.dovepress.com

DovePress

Powered by TCPDF (www.tcpdf.org)

1307

Dovepress

Psychology Research and Behavior Management downloaded from https://www.dovepress.com/ by 174.202.70.172 on 03-Jan-2021
For personal use only.

Lee et al

at least 7 days before hospitalization for HF
decompensation,28 it is not expected to observe dramatic
fluctuations of symptom severity in stable patients with HF
like the sample in our study.
We found that age was associated with a decrease in
the severity of sleep disturbance. However, the rates of
changes were so small (β= −0.004 in both depressive
symptoms and anxiety models) that it is unlikely that
these rates of changes were clinically significant. The
initial scores of symptom severity were not associated
with age in our study. However, there are some studies
demonstrating age differences in symptom perception.
Riegel and colleagues (2010) demonstrated that aging
was associated with poor ability to recognize symptoms
in patients with HF, which may be explained by changes in
the process by which sensory nerve receptors receive and
process stimuli that originate inside the body.29
Unexpectedly, SOB severity scores of patients in
NYHA III/IV were smaller than scores of patients in
NYHA II by 1.5 and 1.6 points in depressive symptom
and anxiety models, respectively. These counter-intuitive
findings may be related to the fact that NYHA functional
class was determined by trained research nurses with a
structural interview, while SOB severity was rated by
patients in their home environment. NYHA functional
classes are determined based on the extent to which HF
symptoms, such as, but not limited to, SOB, limit physical
activity levels. Although NYHA functional class reflects
symptom perception to some extent, this is different from
patients’ perceived SOB severity. A poor agreement
between clinician- and HF patient-rated NYHA classes
(kappa statistic=0. 28) was demonstrated,30,31 which may
indicate the differences between how functional status was
observed by clinicians and perceived by patients
themselves.

Implications
Patients with HF make their decisions to seek care based on
their symptom perception.32 Our findings suggest that differ
ent symptom perception related to depressive symptoms is a
reason for worse outcomes in depressed patients in HF.
Therefore, it is important for clinicians to recognize the
impact of depressive symptoms on symptom perception in
HF patients with depressive symptoms to develop strategies
to improve the accuracy of their symptom perception. One
possible strategy would be a mindfulness-based intervention,
which aims at cultivating a non-judgmental, open, and inten
tional awareness of the present-moment experience (ie,
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mindful awareness).33 From this training, HF patients with
depressive symptoms can learn to accurately perceive their
symptoms without reflecting rumination.

Limitations
One limitation of our study is the relatively small sample
size with the majority of patients who were white and
men. This limits the generalizability of our findings. Data
were imputed to minimize a loss of power. However,
study results were not altered when using the sample
with a complete set of diary data for 15 days. In this
study, the daily diary data on symptoms were collected
using pencil-and-paper diaries. This type of the diary
does not guarantee that patients did complete the diary
on time for 15 days although research nurses highlighted
the importance of completing the diary at the same time
every day. Model fit of the latent growth curve models
was not optimal. However, as this study is an exploratory
purpose, marginal model fit would be satisfactory for this
study. Because the cutoff scores of the BSI for clinically
significant depression and anxiety are not established, the
median split was used to group patients into lower and
higher levels of depressive symptoms and anxiety in this
study. In fact, patients classified as higher levels of
depressive symptoms and anxiety in this study may not
have clinically significant depression and anxiety because
the mean scores of the BSI subscales for depressive
symptoms and anxiety were 0.96 (SD 0.95) and 0.73
(SD 0.80), respectively. However, the mean scores of
the BSI for depressive symptoms and anxiety in previous
studies were below 1.34–36

Conclusion
The findings of our study have significant implications in
relation to poor outcomes in HF patients with negative
emotions, particularly, depressive symptoms. We found
that patient day-to-day symptom experiences were differ
ent by levels of depressive symptoms, but not anxiety.
Given that care-seeking decisions are made based on
symptom perception, inaccurate symptom perception
related to depressive symptoms may be a reason for
worse outcomes in depressed patients in HF. However,
more studies with larger sample sizes are needed to deter
mine why patients with higher levels of depressive symp
toms consistently rated their symptom severity lower than
patients with lower levels of depressive symptoms.
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